Results
1 -
10 of
103Inhibition of erythrocyte ATPase activity by aclacinomycin and reverse effects of ascorbate on ATPase activity, Experientia Treatment of Childhood Acute Nonlymphocytic Leukemia: Cooperative Austrian-Hungarian Study AML-IGCI-84, Acute Leukemias II Low-Dose Aclacinomycin and Intermediate-Dose Cytosine Arabinoside in Relapsed and Refractory Acute Myelogenous Leukemia, New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia Long-term follow-up of the clinical efficacy of chemotherapy for acute myeloid leukemia at a single institute, Journal of Infection and Chemotherapy Absorption, fluorescence and fluorimetric detection limits of naturally occurring quinoid antibiotics and dyes, Microchimica Acta In vitro models for testing of cytostatic agents in small cell lung cancer, Lung Cancer Genotoxicity of Topoisomerase II Inhibitors: Consequences for Chemotherapy, Alternative Mechanisms of Multidrug Resistance in Cancer Clinical Experiences with Aclacinomycin-A, Antitumor Antibiotics Low-Dose Aclacinomycin A in Myelodysplastic Syndromes and Subsequent Acute Myelogenous Leukemia: A Phase II Study, New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia Conserved Cytotoxic Activity of Aclacinomycin A in Multifactorial Multidrug Resistance, Acute Leukemias